Evidence map›Paper›PMID 26748860›Full record

ArticleCellular immunology2016

Vaccine-mediated immunity to experimental Mycobacterium tuberculosis is not impaired in the absence of Toll-like receptor 9.

Archana Gopalakrishnan, Jillian Dietzold, Padmini Salgame

Open access · greenAbstract read
In one paragraph

Article in Cellular immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Peptide-Based Vaccines for Tuberculosis.Frontiers in immunology · 2022
    Review
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Archana GopalakrishnanDepartment of Medicine, Center for Emerging Pathogens, Rutgers, New Jersey Medical School, Newark, NJ, USA; Rutgers-Graduate School of Biomedical Sciences, Newark, NJ, USA.
Jillian DietzoldDepartment of Medicine, Center for Emerging Pathogens, Rutgers, New Jersey Medical School, Newark, NJ, USA; Rutgers-Graduate School of Biomedical Sciences, Newark, NJ, USA.
Padmini SalgameDepartment of Medicine, Center for Emerging Pathogens, Rutgers, New Jersey Medical School, Newark, NJ, USA. Electronic address: salgampa@njms.rutgers.edu.
Rutgers, The State University of New Jersey · US

Funding

TLR2 and the Tubercle GranulomaR01AI084822 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI SALGAME, PADMINI · 2011 to 2015
$1.8M
TLR2 and the Tubercle GranulomaR56AI084822 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI SALGAME, PADMINI · 2009 to 2010
$774k
NIAID NIH HHS AI084822NIAID NIH HHS R01 AI084822NIAID NIH HHS R56 AI084822
6 · The paper itself

Abstract

Accumulating evidence indicates that inflammatory signals required for maximizing effector T cell generation have opposing effects on the development of memory T cell precursors. Toll-like receptor (TLR)2, and TLR9 significantly contribute to the inflammatory milieu and therefore in this study we examined whether the absence of TLR9 alone or the combined absence of TLR2 and TLR9 would affect vaccine-mediated immunity to Mtb. We found that TLR9KO and TLR2/9DKO mice vaccinated with a live Mtb auxotroph, akin to vaccinated WT mice, exhibited early control of Mtb growth in the lungs compared to their naïve counterparts. The granulomatous response, IFNγ production and cellular recruitment to the lungs were also similar in all the vaccinated groups of mice. These findings indicate that there is minimal contribution from TLR2 and TLR9 in generating memory immunity to Mtb with live vaccines. Defining the innate milieu that can drive maximal memory T cell generation with a tuberculosis vaccine needs further inquiry.

Indexed as

AnimalsDisease Models, AnimalFlow CytometryLungMiceMycobacterium tuberculosisToll-Like Receptor 9TuberculosisVaccinesToll-Like Receptor 9VaccinesIL-12Memory immunityMycobacterium tuberculosisToll-like receptor 9Vaccination

Identifiers

PMID26748860
PMCPMC4792693
OpenAlexW2198680254

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.